Article info
PDFClinical science
Cardiovascular risk in patients receiving ranibizumab for exudative age-related macular degeneration: a nationwide self-controlled case-series study
- Correspondence to Dr Ju-Young Shin, School of Pharmacy, Sungkyunkwan University, Suwon, Gyeonggi-do, South Korea; shin.jy{at}skku.edu; Dr Sang Jun Park, Department of Ophthalmology, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, South Korea; sangjunpark{at}snu.ac.kr
Citation
Cardiovascular risk in patients receiving ranibizumab for exudative age-related macular degeneration: a nationwide self-controlled case-series study
Publication history
- Received March 23, 2020
- Revised May 7, 2020
- Accepted May 11, 2020
- First published June 10, 2020.
Online issue publication
January 21, 2022
Article Versions
- Previous version (21 January 2022).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.